Announcement Module
No announcement yet.

Challenges in therapy monitoring

Page Title Module
Move Remove Collapse
Conversation Detail Module
  • Filter
  • Time
  • Show
Clear All
new posts

  • Challenges in therapy monitoring

    A survey in the American Journal of Radiology (issue 195:101-106) depicts today’s challenges in oncological therapy monitoring: Almost all of the approximately 300 participating radiologists confirmed the high importance of tumor measurement for therapy decisions. 86% would likely increase their tumor measurements, if optimized workflows and tools were established. Nevertheless, besides clinical trials, tumors are not always measured in clinical routine.
    Diagnosed September 2009:
    Right orchiectomy
    95% embryonal carcinoma, 4% mature teratoma, 1% yolk sac
    CS2B: Beta HCG: 306, One enlarged Lymphnode (interaortocaval) 3,2x2,9cm. Good prognosis.

    3x BEP, Beta HCG < 0,6, Residual Mass = One enlarged Lymphnode around 0,6x0,7cm, Bilateral L-RPLND: 28 nodes removed - 27 clear, 1 mature teratoma (the enlarged one)

    All clear so far!

    Sorry for my bad english